Skip to content

Study · Animal study (in vivo) · rabbit · 2015

12 results

Effect of Intra-articular Injection of AOD9604 with or without Hyaluronic Acid in Rabbit Osteoarthritis Model.

Kwon DR, Park GY

Annals of clinical and laboratory science1 Jan 2015Cited by 9 (Europe PMC)

PMID26275694 (opens in a new tab)PepBankPUB-26275694

Summary

The text of this summary is not shown here, because the article license does not allow reuse. Read it at the source (opens in a new tab)

Text rights: Publisher copyright. Results still quote short attributed sentences.

Results from this study12

6 results from studies that gave the peptide. No result from this study comes from people.

  1. 01AnimalAnimal study (in vivo)Efficacy outcome

    In rabbits with collagenase-induced knee osteoarthritis, gross morphological scores were significantly lower with AOD9604 alone than with saline.

    In plain wordsIn rabbits with knee arthritis, joint damage scores were lower with AOD9604 than with saline.

    Peptide
    AOD-9604
    Outcome
    DecreaseGross morphological score
    Study

    rabbitn: not reported in source

    collagenase-induced knee osteoarthritis
    Comparator
    Saline (Group 1)
    Outcome group
    Bone and joint · Musculoskeletal
    Studied dose
    0.25 mg AOD9604 weekly · intra-articular · 4-7 weeksAs given in this study (rabbit).

    Source sentences

    Summary
    Mean gross morphological and histopathological scores were significantly higher in Group 1 than in Groups 2, 3, and 4
    2 context sentences
    Summary · context
    Mature New Zealand white rabbits (n=32) were randomly administered 2 mg collagenase type II twice in each knee joint.
    Summary · context
    Weekly injections of 0.6 mL saline (Group 1), 6 mg HA (Group 2), 0.25 mg AOD9604 (Group 3), and 0.25 mg AOD9604 with 6 mg HA (Group 4) were administered for 4-7 weeks after the first intra-articular collagenase injection.
  2. 02AnimalAnimal study (in vivo)Efficacy outcome

    In rabbits with collagenase-induced knee osteoarthritis, histopathological scores were significantly lower with AOD9604 alone than with saline.

    In plain wordsIn rabbits with knee arthritis, cartilage tissue damage scores were lower with AOD9604 than with saline.

    Peptide
    AOD-9604
    Outcome
    DecreaseHistopathological score
    Study

    rabbitn: not reported in source

    collagenase-induced knee osteoarthritis
    Comparator
    Saline (Group 1)
    Outcome group
    Bone and joint · Musculoskeletal
    Studied dose
    0.25 mg AOD9604 weekly · intra-articular · 4-7 weeksAs given in this study (rabbit).

    Source sentences

    Summary
    Mean gross morphological and histopathological scores were significantly higher in Group 1 than in Groups 2, 3, and 4
    2 context sentences
    Summary · context
    Mature New Zealand white rabbits (n=32) were randomly administered 2 mg collagenase type II twice in each knee joint.
    Summary · context
    Weekly injections of 0.6 mL saline (Group 1), 6 mg HA (Group 2), 0.25 mg AOD9604 (Group 3), and 0.25 mg AOD9604 with 6 mg HA (Group 4) were administered for 4-7 weeks after the first intra-articular collagenase injection.
  3. 03AnimalAnimal study (in vivo)Efficacy outcome

    In rabbits with collagenase-induced knee osteoarthritis, gross morphological scores were significantly lower with AOD9604 plus HA than with HA alone.

    In plain wordsIn rabbits with knee arthritis, joint damage scores were lower with AOD9604 plus HA than with HA alone.

    Peptide
    AOD-9604
    Outcome
    DecreaseGross morphological score
    Study

    rabbitn: not reported in source

    collagenase-induced knee osteoarthritis
    Comparator
    HA alone (Group 2)
    Outcome group
    Bone and joint · Musculoskeletal
    Studied dose
    0.25 mg AOD9604 with 6 mg HA weekly · intra-articular · 4-7 weeksAs given in this study (rabbit).

    Source sentences

    Summary
    the scores were significantly lower in Group 4 than in Groups 2 and 3
    2 context sentences
    Summary · context
    Mature New Zealand white rabbits (n=32) were randomly administered 2 mg collagenase type II twice in each knee joint.
    Summary · context
    Weekly injections of 0.6 mL saline (Group 1), 6 mg HA (Group 2), 0.25 mg AOD9604 (Group 3), and 0.25 mg AOD9604 with 6 mg HA (Group 4) were administered for 4-7 weeks after the first intra-articular collagenase injection.
  4. 04AnimalAnimal study (in vivo)Efficacy outcome

    In rabbits with collagenase-induced knee osteoarthritis, histopathological scores were significantly lower with AOD9604 plus HA than with HA alone.

    In plain wordsIn rabbits with knee arthritis, cartilage tissue damage scores were lower with AOD9604 plus HA than with HA alone.

    Peptide
    AOD-9604
    Outcome
    DecreaseHistopathological score
    Study

    rabbitn: not reported in source

    collagenase-induced knee osteoarthritis
    Comparator
    HA alone (Group 2)
    Outcome group
    Bone and joint · Musculoskeletal
    Studied dose
    0.25 mg AOD9604 with 6 mg HA weekly · intra-articular · 4-7 weeksAs given in this study (rabbit).

    Source sentences

    Summary
    the scores were significantly lower in Group 4 than in Groups 2 and 3
    2 context sentences
    Summary · context
    Mature New Zealand white rabbits (n=32) were randomly administered 2 mg collagenase type II twice in each knee joint.
    Summary · context
    Weekly injections of 0.6 mL saline (Group 1), 6 mg HA (Group 2), 0.25 mg AOD9604 (Group 3), and 0.25 mg AOD9604 with 6 mg HA (Group 4) were administered for 4-7 weeks after the first intra-articular collagenase injection.
  5. 05AnimalAnimal study (in vivo)Efficacy outcome

    In rabbits with collagenase-induced knee osteoarthritis, the lameness period was significantly shorter with AOD9604 alone than with saline.

    In plain wordsIn rabbits with knee arthritis, lameness lasted a shorter time with AOD9604 than with saline.

    Peptide
    AOD-9604
    Outcome
    DecreaseLameness period
    Study

    rabbitn: not reported in source

    collagenase-induced knee osteoarthritis
    Comparator
    Saline (Group 1)
    Outcome group
    Bone and joint · Musculoskeletal
    Studied dose
    0.25 mg AOD9604 weekly · intra-articular · 4-7 weeksAs given in this study (rabbit).

    Source sentences

    Summary
    The lameness period in Group 1 was significantly longer than those in Groups 2 and 3.
    2 context sentences
    Summary · context
    Mature New Zealand white rabbits (n=32) were randomly administered 2 mg collagenase type II twice in each knee joint.
    Summary · context
    Weekly injections of 0.6 mL saline (Group 1), 6 mg HA (Group 2), 0.25 mg AOD9604 (Group 3), and 0.25 mg AOD9604 with 6 mg HA (Group 4) were administered for 4-7 weeks after the first intra-articular collagenase injection.
  6. 06AnimalAnimal study (in vivo)Efficacy outcome

    In rabbits with collagenase-induced knee osteoarthritis, the lameness period was significantly shorter with AOD9604 plus HA than with HA alone.

    In plain wordsIn rabbits with knee arthritis, lameness lasted a shorter time with AOD9604 plus HA than with HA alone.

    Peptide
    AOD-9604
    Outcome
    DecreaseLameness period
    Study

    rabbitn: not reported in source

    collagenase-induced knee osteoarthritis
    Comparator
    HA alone (Group 2)
    Outcome group
    Bone and joint · Musculoskeletal
    Studied dose
    0.25 mg AOD9604 with 6 mg HA weekly · intra-articular · 4-7 weeksAs given in this study (rabbit).

    Source sentences

    Summary
    The lameness period in Group 4 was significantly shorter than those in Groups 1, 2, and 3.
    2 context sentences
    Summary · context
    Mature New Zealand white rabbits (n=32) were randomly administered 2 mg collagenase type II twice in each knee joint.
    Summary · context
    Weekly injections of 0.6 mL saline (Group 1), 6 mg HA (Group 2), 0.25 mg AOD9604 (Group 3), and 0.25 mg AOD9604 with 6 mg HA (Group 4) were administered for 4-7 weeks after the first intra-articular collagenase injection.

Studies that did not test the peptide alone6

In this study, AOD-9604 was a lab tool or a carrier, part of a mix, or the subject of a lab method. These results are not evidence about taking AOD-9604.

  1. 07AnimalNot a test of AOD-9604 aloneAnimal study (in vivo)Efficacy outcome

    In rabbits with collagenase-induced knee osteoarthritis, gross morphological scores were significantly lower with AOD9604 plus HA than with saline.

    In plain wordsIn rabbits with knee arthritis, joint damage scores were lower with AOD9604 plus HA than with saline.

    Peptide
    AOD-9604
    Outcome
    DecreaseGross morphological score
    Study

    rabbitn: not reported in source

    collagenase-induced knee osteoarthritis
    Comparator
    Saline (Group 1)
    Outcome group
    Bone and joint · Musculoskeletal

    Source sentences

    Summary
    Mean gross morphological and histopathological scores were significantly higher in Group 1 than in Groups 2, 3, and 4
    2 context sentences
    Summary · context
    Mature New Zealand white rabbits (n=32) were randomly administered 2 mg collagenase type II twice in each knee joint.
    Summary · context
    Weekly injections of 0.6 mL saline (Group 1), 6 mg HA (Group 2), 0.25 mg AOD9604 (Group 3), and 0.25 mg AOD9604 with 6 mg HA (Group 4) were administered for 4-7 weeks after the first intra-articular collagenase injection.

    In this study, AOD-9604 was a lab tool or a carrier, part of a mix, or the subject of a lab method. This result is not evidence about taking AOD-9604.

  2. 08AnimalNot a test of AOD-9604 aloneAnimal study (in vivo)Efficacy outcome

    In rabbits with collagenase-induced knee osteoarthritis, histopathological scores were significantly lower with AOD9604 plus HA than with saline.

    In plain wordsIn rabbits with knee arthritis, cartilage tissue damage scores were lower with AOD9604 plus HA than with saline.

    Peptide
    AOD-9604
    Outcome
    DecreaseHistopathological score
    Study

    rabbitn: not reported in source

    collagenase-induced knee osteoarthritis
    Comparator
    Saline (Group 1)
    Outcome group
    Bone and joint · Musculoskeletal

    Source sentences

    Summary
    Mean gross morphological and histopathological scores were significantly higher in Group 1 than in Groups 2, 3, and 4
    2 context sentences
    Summary · context
    Mature New Zealand white rabbits (n=32) were randomly administered 2 mg collagenase type II twice in each knee joint.
    Summary · context
    Weekly injections of 0.6 mL saline (Group 1), 6 mg HA (Group 2), 0.25 mg AOD9604 (Group 3), and 0.25 mg AOD9604 with 6 mg HA (Group 4) were administered for 4-7 weeks after the first intra-articular collagenase injection.

    In this study, AOD-9604 was a lab tool or a carrier, part of a mix, or the subject of a lab method. This result is not evidence about taking AOD-9604.

  3. 09AnimalNot a test of AOD-9604 aloneAnimal study (in vivo)Efficacy outcome

    In rabbits with collagenase-induced knee osteoarthritis, gross morphological scores were significantly lower with AOD9604 plus HA than with AOD9604 alone.

    In plain wordsIn rabbits with knee arthritis, joint damage scores were lower with AOD9604 plus HA than with AOD9604 alone.

    Peptide
    AOD-9604
    Outcome
    DecreaseGross morphological score
    Study

    rabbitn: not reported in source

    collagenase-induced knee osteoarthritis
    Comparator
    AOD9604 alone (Group 3)
    Outcome group
    Bone and joint · Musculoskeletal

    Source sentences

    Summary
    the scores were significantly lower in Group 4 than in Groups 2 and 3
    2 context sentences
    Summary · context
    Mature New Zealand white rabbits (n=32) were randomly administered 2 mg collagenase type II twice in each knee joint.
    Summary · context
    Weekly injections of 0.6 mL saline (Group 1), 6 mg HA (Group 2), 0.25 mg AOD9604 (Group 3), and 0.25 mg AOD9604 with 6 mg HA (Group 4) were administered for 4-7 weeks after the first intra-articular collagenase injection.

    In this study, AOD-9604 was a lab tool or a carrier, part of a mix, or the subject of a lab method. This result is not evidence about taking AOD-9604.

  4. 10AnimalNot a test of AOD-9604 aloneAnimal study (in vivo)Efficacy outcome

    In rabbits with collagenase-induced knee osteoarthritis, histopathological scores were significantly lower with AOD9604 plus HA than with AOD9604 alone.

    In plain wordsIn rabbits with knee arthritis, cartilage tissue damage scores were lower with AOD9604 plus HA than with AOD9604 alone.

    Peptide
    AOD-9604
    Outcome
    DecreaseHistopathological score
    Study

    rabbitn: not reported in source

    collagenase-induced knee osteoarthritis
    Comparator
    AOD9604 alone (Group 3)
    Outcome group
    Bone and joint · Musculoskeletal

    Source sentences

    Summary
    the scores were significantly lower in Group 4 than in Groups 2 and 3
    2 context sentences
    Summary · context
    Mature New Zealand white rabbits (n=32) were randomly administered 2 mg collagenase type II twice in each knee joint.
    Summary · context
    Weekly injections of 0.6 mL saline (Group 1), 6 mg HA (Group 2), 0.25 mg AOD9604 (Group 3), and 0.25 mg AOD9604 with 6 mg HA (Group 4) were administered for 4-7 weeks after the first intra-articular collagenase injection.

    In this study, AOD-9604 was a lab tool or a carrier, part of a mix, or the subject of a lab method. This result is not evidence about taking AOD-9604.

  5. 11AnimalNot a test of AOD-9604 aloneAnimal study (in vivo)Efficacy outcome

    In rabbits with collagenase-induced knee osteoarthritis, the lameness period was significantly shorter with AOD9604 plus HA than with saline.

    In plain wordsIn rabbits with knee arthritis, lameness lasted a shorter time with AOD9604 plus HA than with saline.

    Peptide
    AOD-9604
    Outcome
    DecreaseLameness period
    Study

    rabbitn: not reported in source

    collagenase-induced knee osteoarthritis
    Comparator
    Saline (Group 1)
    Outcome group
    Bone and joint · Musculoskeletal

    Source sentences

    Summary
    The lameness period in Group 4 was significantly shorter than those in Groups 1, 2, and 3.
    2 context sentences
    Summary · context
    Mature New Zealand white rabbits (n=32) were randomly administered 2 mg collagenase type II twice in each knee joint.
    Summary · context
    Weekly injections of 0.6 mL saline (Group 1), 6 mg HA (Group 2), 0.25 mg AOD9604 (Group 3), and 0.25 mg AOD9604 with 6 mg HA (Group 4) were administered for 4-7 weeks after the first intra-articular collagenase injection.

    In this study, AOD-9604 was a lab tool or a carrier, part of a mix, or the subject of a lab method. This result is not evidence about taking AOD-9604.

  6. 12AnimalNot a test of AOD-9604 aloneAnimal study (in vivo)Efficacy outcome

    In rabbits with collagenase-induced knee osteoarthritis, the lameness period was significantly shorter with AOD9604 plus HA than with AOD9604 alone.

    In plain wordsIn rabbits with knee arthritis, lameness lasted a shorter time with AOD9604 plus HA than with AOD9604 alone.

    Peptide
    AOD-9604
    Outcome
    DecreaseLameness period
    Study

    rabbitn: not reported in source

    collagenase-induced knee osteoarthritis
    Comparator
    AOD9604 alone (Group 3)
    Outcome group
    Bone and joint · Musculoskeletal

    Source sentences

    Summary
    The lameness period in Group 4 was significantly shorter than those in Groups 1, 2, and 3.
    2 context sentences
    Summary · context
    Mature New Zealand white rabbits (n=32) were randomly administered 2 mg collagenase type II twice in each knee joint.
    Summary · context
    Weekly injections of 0.6 mL saline (Group 1), 6 mg HA (Group 2), 0.25 mg AOD9604 (Group 3), and 0.25 mg AOD9604 with 6 mg HA (Group 4) were administered for 4-7 weeks after the first intra-articular collagenase injection.

    In this study, AOD-9604 was a lab tool or a carrier, part of a mix, or the subject of a lab method. This result is not evidence about taking AOD-9604.

AI wrote and checked these results. AI can make mistakes, so check important results against the source.

Version history

PepBank keeps every version of the data on this study. Status changes from Retraction Watch, Europe PMC and Crossref are listed with their source.

  1. Version 2Current

    9 Oct 2026, 18:17 UTC

    Study results updated

  2. Version 1

    9 Oct 2026, 02:47 UTC

    First added · source update from Europe PMC

Subjects

Terms as the source lists them.

PepBank is a research reference. Talk to a doctor before you use any peptide.